InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: dennisczy post# 376

Thursday, 10/03/2019 8:33:32 PM

Thursday, October 03, 2019 8:33:32 PM

Post# of 1141
Thanks for this insight. Indeed the glycoengineering of C1 can change the game for them, but it doesn't have to happen for them to achieve significant commercial success with the platform. I see it as a bonus that could pave the way for biobetters. But with their pipeline of opportunities, R&D partners, cash, and track record, I'm incredibly enthusiastic about the stock price over the next 2-3 years even without success in humanizing C1.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News